A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes ...

Sudden unexpected death in epilepsy (SUDEP) is the leading cause of epilepsy-related deaths in children and adults with ...

It is estimated that one-third of the 50 million people worldwide with epilepsy are resistant to anti-seizure medications.

Epilepsy patients who experience breathing interruptions after a seizure may be at a higher risk of sudden unexpected death ...

Please provide your email address to receive an email when new articles are posted on . No serious device- or implant-related adverse events were reported. A high degree of seizures and related ...

For families of children with severe epilepsy, controlling seizures is often just the beginning of their challenges. Even in ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Sept. 17, 2025 (HealthDay News) — Roughly half of pregnant women with ...

Patients with drug-resistant epilepsy who show no abnormalities on MRI are less likely to achieve seizure freedom following ...

SK Biopharmaceutical’s Xcopri (cenobamate) met the bar in a phase 3 trial that could support the company’s ambitions of ...

People with temporal lobe epilepsy in particular often wander around aimlessly and unconsciously after a seizure. Researchers at the University Hospital Bonn (UKB), the University of Bonn, and the ...

Dozens of people are taking steps toward a world without seizures. Roughly 100 walkers made their way through Kirby Park in ...